Document:

EX-10.1

 Exhibit 10.1 

AMERICAN WELL CORPORATION 

EMPLOYMENT AGREEMENT 
 THIS EMPLOYMENT
AGREEMENT (the “Agreement”) is hereby entered into as of April 8, 2022 (the “Effective Date”) by and between American Well Corporation through its Israeli branch, registration no. 560034696, address at 11
Menachem Begin Road, Ramat Gan, Israel (the “Company”), and Phyllis Gotlib, I.D (the “Executive”) (hereinafter collectively referred to as “the parties”). Where the context requires, references to
the Company shall include the Company’s subsidiaries and affiliates. 
 RECITALS 

WHEREAS, the Executive was employed by the Company as of January 1, 2018 (the “Employment Start Date”) according to an
Employment Agreement, dated January 1, 2018 (the “Employment Agreement); and; 
 WHEREAS, the Company desires to continue to
employ Executive for the period provided in this Agreement, and Executive desires to accept such continued employment with the Company, subject to the terms and conditions set forth herein; 

WHEREAS, the parties mutually agree that this Agreement will cancel and replace the Employment Agreement as of the Commencement Date,
excluding the applicability of Section 14 arrangement in accordance with the General Approval which shall continue to apply; 
 NOW,
THEREFORE, in consideration of the respective agreements of the parties contained herein, it is agreed as follows: 

1.    Commencement Date; Term; Effect on Other Agreements. The employment term (the “Employment Term”) of
Executive’s employment under this Agreement shall be for the period commencing on October 23, 2020 (the “Commencement Date”) and ending on the third (3rd) anniversary of
the Commencement Date. Thereafter, the Employment Term shall extend automatically for consecutive periods of one year unless either party provides notice of non-renewal not less than ninety (90) days
prior to the end of the Employment Term as then in effect. 
 2.    Employment. During the Employment Term: 

 

	 	(a)	 Position and Supervisor: Executive shall be employed as President, American Well International of the
Company and Executive shall perform the duties, undertake the responsibilities and exercise the authority customarily performed, undertaken, and exercised by persons situated in similar executive capacities. Following the Effective Date, to avoid
any inappropriate reporting relationship. the Executive shall report to the Chief Growth Officer; provided, that if (i) the current (as of the Effective Date) Co-Chief Executive Officers are each no
longer the Co-Chief Executive Officers or, individually, the Chief Executive Officer, and (ii) Executive does not at such time report to, or is not designated to report to, the new Chief Executive
Officer, Executive shall have the right to elect to resign for Good Reason in accordance with Sections 6, 7 and 8 of this Agreement. For 

	 	
clarity and notwithstanding anything else set forth herein, all decisions regarding the compensation of the Executive shall be made solely by the compensation committee of the board of directors
of the Company (the “Committee”). 

  

	 	(b)	 Scope of employment: The Employee shall be employed on a full-time basis. In general, work for the
Company shall be performed on Sunday through Thursday, unless determined and instructed otherwise by the Company, as set forth hereunder. The Employee shall work no less than 42 working hours per week, 8.6 working hours per day (and 7.6 hours during
the “Shortened Day”), during regular business hours. Notwithstanding the aforementioned, Employee agrees and acknowledges that due to the Employee’s senior managerial position in the Company and the special amount of trust involved in
the Position in which the Employee shall be employed, the Hours of Work and Rest Law, 1951 (the “Hours of Work and Rest Law”) does not apply to the Employee’s employment. Therefore, the Employee shall not be entitled to receive
payments or any additional pay for overtime working hours, or work performed on Saturdays or Jewish festival holidays and the Shortened Day shall not apply to the Employee. Notwithstanding the foregoing, the Employee shall not be required to work on
Saturdays or Jewish holidays. 

 For the avoidance of doubt, excluding periods of vacation and sick leave to which
Executive is entitled and other service outside of the Company contemplated in this Section 2(b), Executive shall devote Executive’s full professional time and attention to the business and affairs of the Company to
discharge the responsibilities of Executive hereunder. Executive may manage personal and family investments and participate in industry organizations and charitable endeavors, so long as such activities do not interfere with the performance of
Executive’s responsibilities hereunder. In addition, (i) to the extent that the Executive wishes to serve on for-profit boards the Executive can ask for the Company’s Board of Directors
approval; provided, that, the Executive’s three (3) existing board affiliations with respect to Flare Capital Partners, Zahal Disabled Veterans Organization and 8400 – The Health Network and the Executive’s position as a council
member of the Israel American Council are hereby approved, and (ii) the Executive shall be permitted to continue her current part-time role at Flare Capital provided (x) Executive, at all times during the Employment Term, with respect to
any entities which engage in Prohibited Activities (as defined in Section 12(b) below) and in which Flare Capital invests or holds an equity or ownership interest (in any form, whether as a parent, subsidiary, affiliate, joint venture or
otherwise) maintains solely a passive role and does not engage in any executive, officer, management, consultant or other advisory role with such entities, and (y) Executive at all times fully complies with Executive’s obligations set
forth in this Section 2 and Sections 11, 12, 13 and 15 of this Agreement (other than as permitted in this Section 2(b) with respect to passive roles at Flare Capital). It is 

  
 2 

 
understood that, during Executive’s employment by the Company, Executive shall not engage in any activities that constitute a conflict of interest with the interests of the Company or its
direct and indirect subsidiaries. 
  

	 	(c)	 Executive shall be subject to and shall abide by each of the personnel policies applicable to senior
executives, including but not limited to any policy restricting pledging and hedging investments in Company equity by Company executives, any policy the Company adopts regarding the recovery of incentive compensation (sometimes referred to as
“clawback”) and any additional clawback provisions as required by law and applicable listing rules. This Section 2(c) shall survive the termination of the Employment Term. 

 

	 	(d)	 Subject to Sections 6, 7 and 8 hereof, Executive’s employment with the Company is “at will,”
such that each of Executive or the Company has the option to terminate Executive’s employment at any time, with or without advance notice, and with or without Cause or with or without Good Reason. This Agreement does not constitute an express
or implied agreement of continuing or long-term employment. 

 3.    Annual Compensation. 

 

	 	(a)	 Annual Salary. During the Employment Term, Executive shall be paid a gross annual salary of US $485,000
(“Annual Salary”). The Annual Salary shall be payable to Executive in monthly installments at the gross amount of US$ 40,416.66 (the “Monthly Salary”) The Company shall pay the Executive the Monthly Salary until the 9th of
each month, for the previous month. The Monthly Salary shall be paid in NIS, according to the official USD-NIS exchange rate in effect at the date of each payment. An amount equal to 10% of each Monthly Salary
shall be considered as a special compensation paid for the Executive’s obligations set forth in Section 11-17 to this Agreement, including without limitation in connection with non-compete and assignment of inventions (the “Special Compensation”). The Executive shall be obligated to return all Special Compensation amounts received from the Company upon written notice from the
Company following material violation of any of the said obligations set forth in this Agreement, which material violation is not cured, if curable, within thirty (30) days following written notice from the Company. Company maintains the right
to withhold and set off any amounts due to the Executive following such violation, and all such amounts owed to the Company shall bear interest and shall be linked to the Cost of Living Index in accordance with the law. All the above shall not
derogate from any of the Company’s rights pertaining to said violation by the Executive. 

  

	 	(b)	 Annual Bonus. Subject to the terms of the Company’s annual cash bonus program as in effect from
time to time and the provisions hereof, for each 

  
 3 

	 	
fiscal year of the Company ending during the Employment Term (commencing with the 2020 fiscal year), Executive shall be eligible to receive a target annual cash bonus of 100% of Annual Salary
(such target bonus, as may hereafter be increased, the “Target Bonus”). Annual bonuses, if any, will be payable after the close of the applicable fiscal year, but in any event prior to March 15 of the following calendar year.
The criteria for, and attainment of, Executive’s annual bonus will be at the sole discretion of the Committee and may be based on the achievement of both corporate and personal performance objectives. 

 

	 	(c)	 Annual Review. On an annual basis during the Employment Term, the Committee shall review and analyze the
then-current Annual Salary and Target Bonus of Executive for increase (and not decrease except in accordance with subsection (2) of the definition of Good Reason set forth in Exhibit A) and determine, in its discretion, whether adjustments are
necessary or advisable based on merit, to meet industry benchmarks or otherwise, taking into account market practice and the performance of both the Company and Executive; provided, that the Committee shall use the same or similar criteria or
metrics vis a via Executive’s peer level Company executives reporting to the CEO when considering Executive’s Annual Salary and Target Bonus. 

  

	 	(d)	 Equity Incentives. During the Employment Term, Executive shall be eligible for consideration to receive
equity grants in the sole discretion of the Committee under the Company’s 2020 Equity Incentive Plan, as may be amended and restated from time to time (the “Equity Plan”). Any additional grants shall be subject to the
availability of shares at the time of grant and such vesting terms and conditions as may be determined by the Committee in its discretion, and both the amount and type of such grants shall be based on merit, to meet industry benchmarks or otherwise,
taking into account market practice and the performance of both the Company and the Executive; provided, that the Committee shall use the same or similar criteria or metrics when considering Executive’s awards vis a via the grants made to
Executive’s peer level Company executives reporting to the CEO. 

 4.    Share Ownership
Commitment. Executive agrees to comply with any applicable share ownership requirements or guidelines adopted by the Company applicable to Executive, which shall be on the same terms as similarly situated executives of the Company. 

5.    Other Benefits. During the Employment Term: 

 

	 	(a)	 Employee Benefits. Executive shall be eligible to participate in the various benefits offered by the
Company on terms and conditions that are 

  
 4 

	 	
substantially comparable to the other senior executives of the Company. Under this Section Executive shall be entitled to the following benefits: 

 

	 	(i)	 Pension Insurance – The parties shall continue to maintain Managers Insurance and/or Pension Fund
according to the Executive’s choice (“Pension Insurance”). The contribution to the Pension Insurance shall be as follows: (i) the Company shall contribute an amount equal to 6.5% of the Monthly Salary payment for premium
payments (the “Company Contribution”) and an additional 8.33% of the Monthly Salary payment for severance payments; and (ii) the Executive shall contribute 6% of the Monthly Salary payment toward the premiums payable in respect of a
Pension Insurance. In the event the Executive elects to obtain Managers Insurance, the Company Contribution shall include payments toward a Disability Insurance (“Ovdan Kosher Avoda”), which may be included within the Managers Insurance
Policy, for the exclusive benefit of the Executive, provided that the Company’s contribution towards premium payments shall not be less than 5%. For the removal of any doubt, it is hereby clarified that the Company Contribution together with
any payments towards Disability Insurance shall not exceed 7.5% of the Executive’s Monthly Salary. It is hereby agreed that upon termination of employment under this Agreement, the Company shall release to the Executive all amounts accrued in
the Pension Insurance policy of both the Company’s and Executive’s Contributions. However, it is hereby agreed that if the Executive is dismissed under the circumstances defined in Section 16 and/or Section 17 of the Severance
Pay Law or in the event that the Executive withdraws monies from the Pension Insurance in circumstances other than an “Entitling Event”, (i.e., death, disablement or retirement at the age of 60 or over) - the Executive shall not be
entitled to any Severance Pay under the Severance Pay Law. It is hereby clearly agreed and understood that the amounts accrued in the Pension Insurance policy shall be in lieu and in full and final substitution of any severance pay the Executive
shall be or become entitled to under any applicable Israeli law. This section is in accordance with Section 14 of the Severance Pay Law, and the General Approval of the Labor Minister, dated June 30, 1998, issued in accordance to the said
Section 14, a copy of which is attached hereby as Exhibit C. 

  

	 	(ii)	 Education Fund - The Company and the Executive shall continue to maintain a Keren Hishtalmut (the
“Fund”). Use of these funds shall be in accordance with the by-laws of the Fund. The Company shall contribute to the Fund an amount equal to seven and a half percent (7.5%) and the Executive shall
contribute to such Fund an amount equal to two and a half percent (2.5%) of each Monthly Salary payment. Notwithstanding the above, the sums contributed to the Fund will not exceed the limit recognized by the Income Tax Authority from time to time
and the Company will not gross up any tax payable in respect of such contributions. The Executive shall be responsible for any tax imposed in connection with contributions to the Fund, if any. 

  
 5 

	 	(iii)	 Travel Expenses – to the extent the Executive is not under leased car arrangement provided by the Company
in accordance with the then applicable Company’s car policy, the Company shall pay the Executive travel expenses per applicable law and Company policy. 

  

	 	(iv)	 Travel Overseas – Executive shall be entitled to: (a) all flying tickets shall be in business class;
and (b) overseas Per Diem reimbursement in accordance with the then applicable Company’s policy. 

  

	 	(v)	 Cellular Phone Expenses – Executive shall be entitled to reimbursement of monthly charges regarding cell
phone usage for work- related purpose – in accordance with then applicable Company policy. 

  

	 	(vi)	 Sick leave – Executive shall be entitled to sick leave in accordance with applicable law.

  

	 	(vii)	 Annual Vacation Allowance – Executive shall be entitled to an annual vacation allowance of 28 working
days, and not less than applicable law. Executive shall be entitled to accrue up to 28 unused vacation days. 

  

	 	(viii)	 Dmey Havra’ah (Convalescence Pay) – Executive shall be entitled to “Dmey Havra’ah” in
accordance with any applicable law. 

 Benefits may be modified or changed from time to time at the sole discretion of the
Company (but not in a manner discriminatory against Executive), and the provision of such benefits to Executive in no way changes or impacts Executive’s status as an at-will employee. The Company’s
present benefit structure and other important information about the benefits for which Executive may be eligible are described in the Company’s benefits summary booklet and in the Company’s employee handbook. Except as specifically
provided herein, where a benefit is subject to a formal plan, eligibility to participate in and receive any particular benefit is governed solely by the applicable plan document. 

 

	 	(b)	 Business Expenses. Upon submission of proper invoices in accordance with, and subject to, the
Company’s normal policies and procedures, Executive shall be entitled to receive prompt reimbursement of all reasonable out-of-pocket business, entertainment and
travel expenses incurred by Executive in connection with the performance of Executive’s duties hereunder. 

6.    Termination. Executive’s employment with the Company hereunder may be terminated under the circumstances
set forth below;  
  

	 	(a)	 Death. Executive’s employment shall be terminated as of the date of Executive’s death and
Executive’s beneficiaries shall be entitled to the benefits provided in Section 8(b) hereof. 

  
 6 

	 	(b)	 Disability. The Company may terminate Executive’s employment, on written notice to Executive after
having established Executive’s Disability and while Executive remains Disabled – [all in accordance with the requirements of the then applicable law for such reason of termination] and Executive shall be entitled to the benefits provided
in Section 8(b) hereof. For purposes of this Agreement, “Disability” shall have the meaning assigned to such term in the Equity Plan. 

 

	 	(c)	 Cause. The Company may terminate Executive’s employment for Cause (as defined in Exhibit A)
effective as of the date of the Notice of Termination (as defined in Section 7 hereof) and Executive shall be entitled to the benefits provided in Section 8(a) hereof. 

 

	 	(d)	 Without Cause. The Company may terminate Executive’s employment without Cause and Executive shall
be entitled to the benefits provided in Section 8(c) or 8(e) hereof, as applicable. 

  

	 	(e)	 Good Reason. Executive may terminate Executive’s employment with Good Reason (as defined in
Exhibit A), subject to this Section 6(e) and Executive shall be entitled to the benefits provided in Section 8(c) or 8(e) hereof, as applicable. 

 

	 	(f)	 Without Good Reason. Executive may voluntarily terminate Executive’s employment without Good Reason
by delivering to the Company a Notice of Termination not less than thirty (30) days prior to the termination of Executive’s employment and the Company shall have the option of terminating Executive’s duties and responsibilities prior
to the expiration of such thirty (30) day notice period, and Executive shall be entitled to the benefits provided in Section 8(a) hereof through the last day of such notice period. 

 

	 	(g)	 Notice of Non-Renewal. Executive’s employment shall
terminate upon expiration of the Employment Term as then in effect following timely provision by either party of notice of non-renewal in accordance with Section 1 hereof, and
Executive shall be entitled to the benefits provided in Section 8(d) hereof. 

7.    Notice of Termination. Any purported termination by Executive shall be communicated by written Notice of
Termination to the Company. For purposes of this Agreement, a “Notice of Termination” shall mean a notice which indicates a termination date, the specific termination provision in this Agreement relied upon and sets forth in
reasonable detail the facts and circumstances claimed to provide a basis for termination of Executive’s employment under the provision so indicated, all in accordance with applicable Israeli law. For purposes of this Agreement, no such
purported termination of Executive’s employment hereunder shall be effective without such Notice of Termination (unless waived by the party entitled to receive such notice).  

  
 7 

 8.    Compensation Upon Termination. Upon termination of
Executive’s employment during the Employment Term, Executive shall be entitled to the following benefits; provided, however, that any such benefits to which Executive is hereunder entitled shall be offset by those benefits that
Executive receives, if any, under applicable law or otherwise:  
  

	 	(a)	 Termination by the Company for Cause or by Executive Without Good Reason. If Executive’s employment
is terminated by the Company for Cause or by Executive without Good Reason, the Company shall pay Executive all amounts earned or accrued hereunder through the termination date, including: 

 

	 	(1)	 reimbursement for reasonable and necessary expenses incurred by Executive on behalf of the Company for the
period ending on the termination date, pursuant to the procedures of the Company’s applicable policies; 

  

	 	(2)	 any previous compensation which Executive has previously deferred (including any interest earned or credited
thereon), in accordance with the terms and conditions of the applicable deferred compensation plans or arrangements then in effect, including unpaid Base Salary; 

 

	 	(3)	 equity and incentive awards, to the extent previously vested, shall be paid or delivered to Executive in
accordance with the terms of such awards; and 

  

	 	(4)	 any amount or benefit as provided under any benefit plan or program, any accrued, but unpaid vacation and
convalescence pay, release of Pension Insurance and Education Fund and any other statutory rights to which Executive is entitled to upon termination of employment per applicable law (the foregoing items in clauses (1) through (4) being
collectively referred to as the “Accrued Compensation”). 

  

	 	(b)	 Termination by the Company for Disability or Death. If Executive’s employment is terminated by the
Company for Disability or by reason of Executive’s death, then, subject to Section 18(d) hereof, Executive shall be entitled to the benefits provided in this Section 8(b).

  

	 	(1)	 The Company shall pay Executive (or Executive’s beneficiaries, as applicable) the Accrued Compensation;

  

	 	(2)	 The Company shall pay to Executive (or Executive’s beneficiaries, as applicable) within sixty
(60) days following the termination date, any bonus earned but unpaid in respect of any fiscal year preceding the termination date; and 

  
 8 

	 	(3)	 Each unvested equity award held by Executive at the time of termination shall be governed by the terms of the
applicable plan and/or award agreement. 

  

	 	(c)	 Termination by the Company Without Cause or by Executive for Good Reason. If Executive’s employment
by the Company shall be terminated by the Company without Cause or by Executive for Good Reason (other than as provided in Section 8(e)), then, subject to Section 18(d) hereof, Executive shall be
entitled to the benefits provided in this Section 8(c). 

  

	 	(1)	 The Company shall pay to Executive any Accrued Compensation; 

 

	 	(2)	 The Company shall pay to Executive any bonus earned but unpaid in respect of any fiscal year preceding the
termination date within sixty (60) days following the termination date; 

  

	 	(3)	 The Company shall pay to Executive in a lump sum within the time period set forth in, a pro rata bonus equal to
the product of (x) Executive’s Target Bonus and (y) a fraction, equal to the number of days Executive was employed during the applicable fiscal year divided by three hundred sixty-five (365) (the “Pro Rata Bonus”);

  

	 	(4)	 The Company shall pay Executive as Special Severance Pay, in lieu of any further compensation (except as
provided in this Section 8(c) or under Section 5(a) hereof) for the periods subsequent to the termination date, an amount in cash calculated as follows: 

One (1) times Executive’s then-current gross Annual Salary minus the amount contributed by the Company and accumulated pursuant to
Section 5(a) hereof for severance pay in the severance component of the Executive’s Pension Insurance at the Termination Date, including any revenues accumulated at the fund for the severance component. For the avoidance of doubt, the
foregoing offset shall not include amounts contributed and accumulated from Employee’s direct and personal contributions.  

The Special Severance Pay shall be paid in equal gross installments on the Company’s regular payroll dates during the twelve
(12) month period following the date on which Executive executes a release and the revocation period expires in accordance with Section 18(d) hereof (the “Adjustment Period”); and 

 

	 	(5)	 Each unvested equity award held by Executive at the time of termination shall be governed by the terms of the
applicable plan and/or award agreement. 

  
 9 

	 	(d)	 Expiration of Employment Term Upon Notice of Non-Renewal. If
Executive’s employment terminates upon expiration of the Employment Term as then in effect following timely provision by either party of notice of non-renewal in accordance with
Section 1 hereof, then, subject to Section 18(d) hereof, Executive shall be entitled to the benefits provided in this Section 8(d). 

 

	 	(1)	 The Company shall pay to Executive any Accrued Compensation; and 

 

	 	(2)	 Each unvested equity award held by Executive at the time of termination shall be treated in accordance with the
terms of the applicable plan and/or award agreement governing a termination of employment other than for cause or due to death or disability. 

  

	 	(e)	 Change in Control Termination. Notwithstanding any other provision contained herein, if Executive’s
employment by the Company shall be terminated by the Company without Cause or by Executive for Good Reason, in each case within one month before or twenty-four (24) months immediately following a Change in Control (as defined under the Equity
Plan), then, subject to Section 18(d) hereof, Executive shall be entitled to the benefits provided in this Section 8(e). 

 

	 	(1)	 The Company shall pay to Executive any Accrued Compensation; 

 

	 	(2)	 The Company shall pay to Executive any bonus earned but unpaid in respect of any fiscal year preceding the
termination date within sixty (60) days following the termination date; 

  

	 	(3)	 The Company shall pay to Executive an amount equal to Executive’s then-current Target Bonus within thirty
(30) days following the termination date; 

  

	 	(4)	 The Company shall pay Executive as Special Severance Pay, in lieu of any further compensation (except as
provided in this Section 8(e) or under Section 5(a) hereof) for the periods subsequent to the termination date, an amount in cash, calculated as detailed in Section 8 (c)(4), paid in equal
installments on the Company’s regular payroll dates during the Adjustment Period. 

  

	 	(5)	 Each unvested equity award held by Executive at the time of termination shall vest in full (with any applicable
performance goals treated as achieved at target). 

  

	 	(f)	 Executive shall not be required to mitigate the amount of any payment provided for under this
Section 8 by seeking other employment or otherwise and no such payment shall be offset or reduced by the amount of any compensation or benefits provided to Executive in any subsequent employment. 

  
 10 

 9.    Section 409A. This Agreement is intended to comply with, or
otherwise be exempt from, Section 409A, to the extent applicable. With respect whereof, the Company shall undertake to administer, interpret and construe this Agreement, to the extent reasonably practicable, in a manner that does not result in
the imposition on Executive of any additional tax, penalty or interest under Section 409A. If the Company determines in good faith that any provision of this Agreement would cause Executive to incur an additional tax, penalty or interest under
Section 409A, the Company and Executive shall use reasonable efforts to reform such provision, if possible, in a mutually agreeable fashion to maintain to the maximum extent practicable the original intent of the applicable provision without
violating the provisions of Section 409A. If a payment obligation under this Agreement arises on account of Executive’s separation from service while Executive is a “specified employee” (as defined under Section 409A), then
any payment that constitutes “deferred compensation” (as defined under Treasury Regulation Section 1.409A-1(b)(1), after giving effect to the exemptions in Treasury Regulation Sections 1.409A-1(b)(3) through (b)(12)) that is scheduled to be paid within six (6) months after such separation from service shall accrue without interest and shall be paid within fifteen (15) days after the end
of the six (6) month period beginning on the date of such separation from service or, if earlier, within fifteen (15) days after the appointment of the personal representative or executor of Executive’s estate following
Executive’s death. Notwithstanding the foregoing, nothing in this Agreement or otherwise is intended to, nor does it, guarantee that the payments and benefits under this Agreement will not be subject to any additional tax or other adverse tax
consequences under Section 409A or any similar state or local tax law. For purposes of Section 409A, any series of installment payments under this Agreement shall be treated as a right to a series of separate payments. 

10.    Employee Protection. Nothing in this Agreement or otherwise limits Executive’s ability to communicate
directly with and provide information, including documents, not otherwise protected from disclosure by any applicable law or privilege to the Securities and Exchange Commission (the “SEC”), any other federal, state or local governmental
agency or commission (“Government Agency”) or self-regulatory organization regarding possible legal violations, without disclosure to the Company. The Company may not retaliate against Executive for any of these activities, and
nothing in this Agreement or otherwise requires Executive to waive any monetary award or other payment that Executive might become entitled to from the SEC or any other Government Agency or self-regulatory organization. 

11.    Records and Confidential Data. 
  

	 	(a)	 Executive acknowledges that in connection with the performance of Executive’s duties during the Employment
Term, the Company will make available to Executive, or Executive will have access to, certain Confidential Information (as defined below) of the Company and its affiliates. Executive acknowledges and agrees that any and all Confidential Information
disclosed to, or learned or obtained by, Executive during the course of Executive’s employment by the Company or otherwise, whether developed by Executive alone or in conjunction with others or otherwise, shall be and is the sole and exclusive
property of the Company and its affiliates and Executive hereby assigns to the Company any and all right, title and interest Executive may have or acquire in and to such Confidential Information. 

  
 11 

	 	(b)	 Except as provided in Section 10 hereof, the Confidential Information will be kept
confidential by Executive, will not be used in any manner which is detrimental to the Company, will not be used other than in connection with Executive’s discharge of Executive’s duties hereunder, and will be safeguarded by Executive from
unauthorized disclosure. Executive acknowledges and agrees that the confidentiality restrictions set forth herein shall apply to any and all Confidential Information disclosed to, or learned, created or obtained by, Executive, whether before, on or
after the date hereof. For the avoidance of doubt, nothing in this Section 11(b) shall prevent Executive from complying with a valid legal requirement (whether by oral questions, interrogatories, requests for information or
documents, subpoena, civil or criminal investigative demand or similar process) to disclose any Confidential Information or from exercising any legally protected whistleblower rights (including under Rule 21F under the Securities Exchange Act of
1934, as amended) as set forth in Section 10. Executive may also provide Confidential Information to Executive’s legal or financial advisors so long as such persons agree to abide by the terms of this Section 11.

  

	 	(c)	 Following the termination of Executive’s employment hereunder, as soon as possible after the
Company’s written request, Executive will return to the Company all Confidential Information which has been provided to Executive and Executive will return or destroy (or cooperate with any reasonable Company requested process to return or
destroy) all copies of any analyses, compilations, studies or other documents (including any email or other electronic correspondence) prepared by Executive or for Executive’s use, or which are otherwise in Executive’s possession or
control, containing or reflecting any Confidential Information, except as provided in Section 10. Within five (5) business days of the receipt of such request by Executive, Executive shall, upon written request of the
Company, deliver to the Company a document certifying that such written Confidential Information has been returned or destroyed in accordance with this Section 11(c). 

 

	 	(d)	 For the purposes of this Agreement, “Confidential Information” shall mean all confidential and
proprietary information of the Company and its subsidiaries, including, without limitation, information derived from reports, investigations, experiments, research, work in progress, drawings, designs, plans, proposals, codes, marketing and sales
programs, client lists, client mailing lists, supplier lists, financial projections, cost summaries, pricing formula, marketing studies relating to prospective business opportunities and all other know-how,
trade secrets, inventions, concepts, ideas, materials, or information developed, prepared or performed for or by 

  
 12 

	 	
the Company or its subsidiaries (in each case, including any email or other electronic correspondence). For purposes of this Agreement, the Confidential Information shall not include and
Executive’s obligations shall not extend to information that Executive can demonstrate with competent evidence is (i) generally available to the public )or within the Company’s industry) without any action or involvement by Executive,
(ii) independently obtained by Executive from a third party on a non-confidential and authorized basis, or (iii) was known to Executive prior to engagement with the Company. Notwithstanding anything
in this Section 11 to the contrary, Executive may disclose Confidential Information: (1) as set forth in Section 10; and (2) to the extent it is required to be disclosed by law or
pursuant to judicial process or administrative subpoena or as reasonably necessary pursuant to any litigation or arbitration between Executive and the Company. To the extent that Confidential Information is required to be disclosed by law,
governmental investigation or pursuant to judicial process or administrative subpoena, Executive shall, to the extent legally permitted, first give written notice to the Company and reasonably cooperate with the Company (at the Company’s
expense) to obtain a protective order or other measures preserving the confidential treatment of such Confidential Information and requiring that the information or documents so disclosed be used only for the purposes required by law, governmental
investigation or pursuant to judicial process or administrative subpoena, except as provided in Section 10 and subject to Section 11(e). 

 

	 	(e)	 Notwithstanding anything in this Agreement to the contrary, pursuant to the Defend Trade Secrets Act of 2016,
the parties hereto acknowledge and agree that Executive shall not have criminal or civil liability under any federal or state trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a federal, state, or
local government official, either directly or indirectly, or to an attorney and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or
other proceeding, if such filing is made under seal. In addition and without limiting the preceding sentence, if Executive files a lawsuit for retaliation by the Company for reporting a suspected violation of law, Executive may disclose the trade
secret to Executive’s attorney and may use the trade secret information in the court proceeding, if Executive (X) files any document containing the trade secret under seal and (Y) does not disclose the trade secret, except pursuant to
court order. 

  

	 	(f)	 In connection with Executive’s employment with the Company, Executive will not use any confidential or
proprietary information Executive may have obtained in connection with employment with any prior employer. 

  

	 	(g)	 Executive recognizes that the Company received and will receive confidential or proprietary information from
third parties, subject to a duty on the Company’s part to maintain the confidentiality of such information 

  
 13 

	 	
and to use it only for certain limited purposes. In connection with such duties, such information shall be deemed Confidential Information hereunder, mutatis mutandis. 

 

	 	(h)	 Executive’s obligations under this Section 11 shall survive the termination of
the Employment Term. 

 12.    Covenant Not to Solicit and Not to Compete; Non-Disparagement. 
  

	 	(a)	 Covenants Not to Solicit or to Interfere. To protect the Confidential Information, Company Intellectual
Property (as defined below) and other trade secrets of the Company and its subsidiaries, Executive agrees, during the Employment Term and for a period of twelve (12) months after Executive’s cessation of employment with the Company, not to
solicit, hire or participate in or assist in any way in the solicitation or hire of any employees of the Company or any of its subsidiaries (or any person who was an employee of the Company or any of its subsidiaries during the six-month period preceding such action) in any country. For purposes of this covenant, “solicit” or “solicitation” means directly or indirectly influencing or attempting to
influence employees of the Company or any of its subsidiaries to become employed with any other person, partnership, firm, corporation, or other entity. 

In addition, to protect the Confidential Information, Company Intellectual Property and other trade secrets of the Company and its
subsidiaries, Executive agrees, during the Employment Term and for a period of twelve (12) months after Executive’s cessation of employment with the Company, not to (x) solicit any client or customer to receive services or to purchase
any goods or services in competition with those provided by the Company or any of its subsidiaries or (y) interfere or attempt to interfere in any material respect with the relationship between the Company or any of its subsidiaries on one hand
and any client, customer, supplier, investor, financing source or capital market intermediary on the other hand, in any country. For purposes of this covenant, “solicit” or “solicitation” means directly or
indirectly influencing or attempting to influence clients or customers of the Company or any of its subsidiaries to accept the services or goods of any other person, partnership, firm, corporation or other entity in competition with those provided
by the Company or any of its subsidiaries. 
 Executive agrees that the covenants contained in this Section 12(a)
are reasonable and desirable to protect the Confidential Information and Company Intellectual Property of the Company and its subsidiaries; provided that solicitation through general advertising or the provision of references shall not
constitute a breach of such obligations. 

  
 14 

	 	(b)	 Covenant Not to Compete. To protect the Confidential Information, Company Intellectual Property and
other trade secrets of the Company and its subsidiaries, and in specific consideration for payment of the Special Compensation Executive agrees, to the maximum extent permitted by applicable law, not to become involved with any entity that directly
or indirectly engages in Prohibited Activities (as defined below) in any country in which the Company or any of its subsidiaries conducts such business, or plans to conduct such business during the Employment Term, during the period commencing with
the Employment Term and ending twelve (12) months after Executive’s cessation of employment with the Company for any reason. For the purposes of this Agreement, the term “Prohibited Activities” means directly or indirectly
owning any interest in, managing, participating in (whether as an employee, director, officer, consultant, partner, member, manager, representative or agent), consulting with or rendering services to any entity (including, without limitation, Doctor
On Demand, MDLive, Teladoc, Epic Systems, Cerner or Zoom) in (A) the telehealth industry or (B) digital healthcare, that, in the case of clause (B), performs or plans to perform any of the services or manufactures or sells or plans to
manufacture or sell any of the products planned, provided or offered by the Company or any of its subsidiaries or any products or services designed to perform the same function or achieve the same results as the products or services planned,
provided or offered by the Company or any of its subsidiaries or performs or plans to perform any other services and/or engages or plans to engage in the development, production, manufacture, distribution or sale of any product similar to any
planned or actual services performed or products developed, produced, manufactured, distributed or sold by the Company or any of its subsidiaries during the term of Executive’s employment with the Company and its subsidiaries, including,
without limitation, any business activity that directly or indirectly provides the research, development, manufacture, marketing, selling or servicing of systems facilitating consumer communications with professional service providers in the digital
healthcare field; provided that (i) Prohibited Activities shall not mean Executive’s investment in securities of a publicly-traded company (or a non-publicly traded entity through a passive
investment) equal to less than five percent (5%) of such company’s outstanding voting securities, (ii) Prohibited Activities following cessation of Executive’s employment shall not include businesses of the Company or its subsidiaries
which are reasonably projected, as of the termination date, to represent less than 5% of the consolidated revenues of the Company and its subsidiaries taken as a whole following the termination date, and (iii) Executive shall be permitted to
provide services to an entity that has a unit, division, subsidiary or affiliate engaging in a Prohibited Activity so long as Executive does not provide services, directly or indirectly, to such unit, division, subsidiary or affiliate engaging in
the Prohibited Activity. Executive agrees that the covenants contained in this Section 12(b) are (i) reasonable and desirable to protect the Confidential Information and

  
 15 

	 	
Company Intellectual Property of the Company and its subsidiaries ; (ii) the area and time duration thereof are in all things reasonable and necessary to protect the goodwill and the operations
and business of Company and its subsidiaries , and does not impose a greater restrain than is necessary to protect the goodwill or other business interests of the Company, and (iii) good and valuable consideration exists under the Agreement,
for Executive’s agreement to be bound thereby. Notwithstanding, if any of the restrictions set forth herein is found by a court having jurisdiction to be unreasonable or overly-broad as to geographic area, scope or time or to be otherwise
unenforceable, the Parties hereto intend for the restrictions set forth herein to be reformed, modified and redefined by such court so as to be reasonable and enforceable and, as so modified by such court, to be fully enforced. Any reference to
plans or planned activity in this paragraph shall be limited to plans or planned activities that are based upon material demonstrable actions. Following Executive’s cessation of employment, the prohibitions in this paragraph shall be limited to
activities and planned activities (including locations) as of the date of Executive’s termination of employment. 

  

	 	(c)	 Non-Disparagement. Executive agrees not to make written or oral
statements about the Company, its subsidiaries or affiliates, or its directors, executive officers or non-executive officer employees that are negative or disparaging, except as provided in
Section 10 hereof or in the ordinary course of personnel performance reviews when making such statements is reasonable and appropriate. The Company, as represented by its directors and executive officers, shall not make
written or oral statements about Executive that are negative or disparaging, except as provided in Section 10 hereof or in the ordinary course of personnel performance reviews when making such statements is reasonable and
appropriate. Notwithstanding the foregoing, nothing in this Agreement or otherwise shall preclude Executive, the Company, its subsidiaries and affiliates, and the Company’s directors and executive officers from communicating or testifying
truthfully to the extent required by law to any federal, state, provincial or local governmental agency or in response to a subpoena to testify issued by a court of competent jurisdiction or in connection with any litigation or arbitration between
Executive and the Company or any of its affiliates or any of its directors, executive officers or non-executive officer employees. Either party may make truthful statements to the extent reasonably necessary
to correct any inaccurate public statements made by the other party (including executives or directors of the Company) or in the normal course of permitted competitive actions. 

 

	 	(d)	 It is the intent and desire of Executive and the Company that the restrictive provisions of this
Section 12 be enforced to the fullest extent permissible under the laws and public policies as applied in each jurisdiction in which enforcement is sought. If any particular provision of this
Section 12 shall be determined to be invalid or unenforceable, such covenant shall be 

  
 16 

	 	
amended, without any action on the part of either party hereto, to delete therefrom the portion so determined to be invalid or unenforceable, such deletion to apply only with respect to the
operation of such covenant in the particular jurisdiction in which such adjudication is made. 

  

	 	(e)	 Executive’s obligations under this Section 12 shall survive the termination of
the Employment Term. 

 13.    Remedies for Breach of Obligations under Sections 11
or 12 hereof. Executive acknowledges that the Company may suffer irreparable injury, not readily susceptible of valuation in monetary damages, if Executive breaches Executive’s obligations under Sections 11 or 12 hereof.
Accordingly, Executive agrees that the Company will be entitled, in addition to any other available remedies, to seek injunctive relief against any breach or prospective breach by Executive of Executive’s obligations under Sections 11 or
12 hereof. Executive agrees that process in any or all of those actions or proceedings may be served by registered mail, addressed to the last address provided by Executive to the Company, or in any other manner authorized by law. This
Section 13 shall survive the termination of the Employment Term. 
 14.    Cooperation.

  

	 	(a)	 For a period of thirty-six (36) months following Executive’s
termination of employment for any reason, except as provided in Section 10 hereof, Executive agrees to make Executive reasonably available at the request of the Company to cooperate with the Company and its affiliates in
matters that materially concern: (i) requests for information about the services Executive provided to the Company and its affiliates during Executive’s employment with the Company and its affiliates, (ii) the defense or prosecution
of any claims or actions now in existence or which may be brought in the future against or on behalf of the Company and its affiliates which relate to events or occurrences that transpired while Executive was employed the Company and its affiliates
and as to which Executive has, or would reasonably be expected to have, personal experience, knowledge or information or (iii) any investigation or review by any federal, state or local regulatory, quasi-regulatory or self-governing authority
(including, without limitation, the US Department of Justice, the US Federal Trade Commission or the SEC) as any such investigation or review relates to events or occurrences that transpired while Executive was employed by the Company and its
affiliates. Executive’s cooperation shall include: (A) making Executive reasonably available to meet and speak with officers or employees of the Company, the Company’s counsel or any third-parties at the reasonable request of the
Company at times and locations to be determined by the Company reasonably and in good faith, taking into account the Company’s business and Executive’s business and personal needs (the “Company Cooperation”) and
(B) giving accurate and truthful information at any interviews and accurate and truthful testimony in any legal proceedings or actions (the “Witness Cooperation”). Nothing in this Section 14(a) shall
be construed to limit in any way any rights Executive 

  
 17 

	 	
may have at applicable law not to provide testimony with regard to specific matters. Unless required by law or legal process, Executive will not knowingly or intentionally furnish information to
or cooperate with any non-governmental entity (other than the Company) in connection with any potential or pending proceeding or legal action involving matters arising during Executive’s employment with
the Company and its affiliates, except as provided in Section 10. In addition, at the request of the Company, Executive shall be required annually to complete a directors’ and officers’ questionnaire to facilitate
the Company’s preparation of any filings and reports with the SEC.  

  

	 	(b)	 Executive shall not be entitled to any payments in addition to those otherwise set forth in this Agreement in
respect of any Company Cooperation or Witness Cooperation, regardless of when provided. The Company will reimburse Executive for any reasonable, out-of-pocket travel,
hotel and meal expenses incurred in connection with Executive’s performance of obligations pursuant to this Section 14 for which Executive has obtained prior approval (which shall not be unreasonably withheld) from the
Company. Executive shall not be required to cooperate against Executive’s own legal interests. 

  

	 	(c)	 Nothing in this Agreement or any other agreement by and between the parties is intended to or shall preclude or
in any way limit or restrict Executive from providing accurate and truthful testimony or information to any governmental agency. 

  

	 	(d)	 This Section 14 shall survive the termination of the Employment Term.

 15.    Inventions and Intellectual Property. 

 

	 	(a)	 Definitions. As used in this Agreement: 

 

	 	(1)	 “Intellectual Property” means all patents, invention disclosures, invention registrations,
trademarks, service marks, trade names, trade dress, logos, domain names, copyrights, mask works, trade secrets, know-how and all other intellectual property and proprietary rights recognized by any applicable
law of any jurisdiction, and all registrations and applications for registration of, and all goodwill associated with, the foregoing. 

  

	 	(2)	 “Inventions” means all inventions, discoveries, concepts, information, works, materials,
processes, methods, data, software, programs, apparatus, designs, and the like. 

  

	 	(b)	 Disclosure. Executive will disclose promptly in writing to the Company any and all Inventions and
Intellectual Property, in each case that Executive conceives, develops, creates or reduces to practice, or has conceived, developed, created or reduced to practice, either alone or jointly with others,

  
 18 

	 	
during the period of Executive’s employment, whether prior to or after the Effective Date, that (1) are, or were, conceived, created or developed using any equipment, supplies,
facilities, trade secrets, know-how or other Confidential Information of the Company or any of its affiliates, (2) result, or resulted, from any work performed by Executive for the Company or any of its
affiliates and/or (3) otherwise relate to the Company’s or any of its affiliates’ business or actual or demonstrably anticipated research or development (collectively, “Company Intellectual Property”).

  

	 	(c)	 Ownership and Assignment. Executive acknowledges and agrees that the Company has and will have exclusive
title and ownership rights in and to all Company Intellectual Property. To the extent that exclusive title and/or ownership rights may not originally vest in the Company as contemplated herein (or did not so vest), Executive hereby irrevocably
assigns, transfers, conveys and delivers to the Company all right, title and interest in and to any and all Company Intellectual Property. Executive acknowledges and agrees that, with respect to any Company Intellectual Property that may qualify as
a Work Made For Hire as defined in 17 U.S.C. § 101 or other applicable law, such Company Intellectual Property is and will be deemed a Work Made for Hire and the Company has and will have the sole and exclusive right to the copyright (or, in
the event that any such Company Intellectual Property does not qualify as a Work Made for Hire, the copyright and all other rights thereto are hereby automatically and irrevocably assigned to the Company as above). Further, and for the avoidance of
any doubt, it is hereby clarified that the provisions contained herein will apply also to any “Service Inventions” as defined in the Israeli Patent Law, 1967 (the “Patent Law”). In no event will such Service
Invention become the property of the Executive, and the provisions contained in Section 132(b) of the Patent Law shall not apply, unless the Company provides in writing otherwise. The Executive will not be entitled to royalties or other
payment, monetary compensation or other consideration with regard to any Prior Inventions, Inventions, Service Inventions or any of the intellectual property rights set forth herein, including any commercialization thereof, and the Executive hereby
specifically and irrevocably waives any right the Executive may have to such payment (including, inter-alia, in relation with Section 134 of the Patent Law). With respect to all of the above, any oral understanding, communication or
agreement not duly signed by the Company shall be void. 

  

	 	(d)	 Prior Inventions. Set forth in Exhibit B (Prior Inventions) attached hereto is a complete list of
all Inventions that Executive has, alone or jointly with others, conceived, developed created or reduced to practice prior to the commencement of Executive’s employment with the Company, that are Executive’s property, and that the Company
acknowledges and agrees are excluded from the scope of this Agreement (collectively, “Prior Inventions”). If disclosure of any such Prior Invention would cause Executive to violate any prior confidentiality agreement, Executive

  
 19 

	 	
understands that Executive is not to list such Prior Inventions in Exhibit B but is only to disclose where indicated a cursory name for each such Prior Invention, a
listing of each person or entity to whom it belongs, and the fact that full disclosure as to such Prior Inventions has not been made for that reason (it being understood that, if no Invention or disclosure is provided in
Exhibit B, Executive hereby represents and warrants that there are no Prior Inventions). If, in the course of Executive’s employment with the Company, Executive incorporates any Prior Invention into any Company
product, process or machine or otherwise uses any Prior Invention, Executive hereby grants to the Company and its affiliates a worldwide, non-exclusive, irrevocable, perpetual, fully paid-up and royalty-free license (with rights to sublicense through multiple tiers of sublicensees) to use, reproduce, modify, make derivative works of, publicly perform, publicly display, make, have made, sell,
offer for sale, import and otherwise exploit such Prior Invention for any purpose. 

  

	 	(e)	 Non-Assignable Inventions. If Executive transfers
Executive’s principal work location to California, Illinois, Kansas, Minnesota, Washington State or any other state that has codified applicable law, the provisions regarding Executive’s assignment of Company Intellectual Property to the
Company in Section 15(c) hereof shall not apply to certain Inventions (“Non-Assignable Inventions”) as specified in the statutory code of the applicable state.
Executive acknowledges having received and reviewed notification regarding such Non-Assignable Inventions pursuant to such states’ codes. 

 

	 	(f)	 Waiver of Moral Rights. To the extent that Executive may do so under applicable law, Executive hereby
transfers to the Company any and all Moral Rights that Executive may possess or acquire in or with respect to any Company Intellectual Property. Insofar as any of Executive’s Moral Rights cannot be so assigned or transferred, to the extent that
Executive may do so under applicable law, Executive hereby waives and agrees never to assert any Moral Rights that Executive may have in or with respect to any Company Intellectual Property, even after termination of any work on behalf of the
Company. As used in this Agreement, “Moral Rights” means any and all rights to claim authorship of a work, to object to or prevent the modification or destruction of a work, or to withdraw from circulation or control the publication
or distribution of a work, and any similar right, existing under any applicable law of any jurisdiction, regardless of whether or not such right is denominated or generally referred to as a “moral right.” 

 

	 	(g)	 Further Assurances. Executive shall give the Company and its affiliates all reasonable assistance and
execute all documents necessary to assist with enabling the Company and its affiliates to prosecute, perfect, register, record, enforce and defend any of their rights in any Company Intellectual Property and Confidential Information.

  

	 	(h)	 This Section 15 shall survive the termination of the Employment Term.

  
 20 

 16.    Media Equipment; Professional Email Account; Inspection

  

	 	(a)	 The Company may provide the Executive with a cellular phone, a computer, an electronic mail account or any
other property or equipment of the Company for purposes of the Executive’s communication (the “Media Equipment”). Employee acknowledges, agrees and consents that (i) the email account provided thereto by the Company (the
“Professional Email Account”) will be utilized solely for the performances of Executive’s duties in accordance with the Agreement and not for any private use, (ii) all of the Media Equipment is the property of the Company,
and (iii) the Company may enter the Professional Email Account at any time and for any purpose. The aforementioned does not limit the Executive from using a private email account during working hours, provided Executive’s responsibilities
toward the Company are not adversely affected by such use. 

  

	 	(b)	 Without derogating from the aforesaid, the Executive acknowledges and agrees that the Company is entitled to
conduct inspections within the Company’s offices and on the Media Equipment, including the inspections of the Professional Email Account and other electronic mail transmissions, internet usage, message texting and their content. For the
avoidance of any doubt, it is hereby clarified that all inspections’ finding shall be the exclusive property of the Company. The Executive acknowledges that, in order to maintain Executive’s privacy, Executive should avoid any personal or
private use of the Media Equipment and any other property or equipment of the Company. The Executive hereby grants the Company an irrevocable right to conduct such aforesaid inspections, including unannounced inspections. 

17.    Restriction on “Open Source” Software. 

 

	 	(a)	 Executive shall not, without the prior written consent of Company, incorporate into any computer software of
Company any “open source” software (as such term is generally understood in the computer software industry). 

18.    Miscellaneous.  
  

	 	(a)	 Successors and Assigns. 

 

	 	(1)	 This Agreement shall be binding upon and shall inure to the benefit of the Company, its successors and
permitted assigns. The Company may not assign or delegate any rights or obligations hereunder except to a successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or
assets of the Company, as applicable. The term “the Company” as used herein shall mean a corporation or other entity acquiring all or substantially all the assets and business of the Company, as the case may be, (including this
Agreement) whether by operation of law or otherwise. 

  
 21 

	 	(2)	 Neither this Agreement nor any right or interest hereunder shall be assignable or transferable by Executive,
Executive’s beneficiaries, or legal representatives, except by will or by the, laws of descent and distribution. 

  

	 	(3)	 This Agreement shall inure to the benefit of and be enforceable by Executive’s legal personal
representatives, and by Executive’s beneficiaries in the event of Executive’s death. 

  

	 	(b)	 Notice. For the purposes of this Agreement, notices and all other communications provided for in the
Agreement (including the Notice of Termination) shall be in writing and shall be deemed to have been duly given when personally delivered or sent by Certified mail, return receipt requested, postage prepaid, addressed to the respective addresses
last given by each party to each other party; provided that all notices to the Company shall be directed to the attention of the General Counsel of the Company. All notices and communications shall be deemed to have been received on the date
of delivery thereof or on the third business day after the mailing thereof, except that notice of change of address shall be effective only upon receipt. 

  

	 	(c)	 Withholding. The Company shall be entitled to withhold the amount, if any, of all taxes of any
applicable jurisdiction required to be withheld by an employer with respect to any amount paid to Executive hereunder. The Company, in its sole and absolute discretion, shall make all determinations as to whether it is obligated to withhold any
taxes hereunder and the amount hereof. 

  

	 	(d)	 Release of Claims. The termination benefits described in Sections 8(b), 8(c), 8(d), and
8(e) hereof (the “Total Payments”) shall be conditioned on Executive delivering to the Company, and failing to revoke, a signed release of claims in the form attached hereto as Exhibit [    ] within fifty
(50) days following Executive’s termination date. Notwithstanding any provision of this Agreement to the contrary, in no event shall the timing of Executive’s execution of the release, directly or indirectly, result in Executive
designating the calendar year of payment, and, to the extent required by Section 409A, if a payment that is subject to execution of the release could be made in more than one taxable year, payment shall be made in the later taxable year. Where
applicable, references to Executive in this Section 18(d) shall refer to Executive’s representative or estate. 

  

	 	(e)	 Parachute Payments. To the extent consistent with applicable law, the payment of any amounts or the
provision of any benefits under this Agreement or any other agreement including, without limitation, the Total 

  
 22 

	 	
Payments, will be reduced or adjusted to avoid triggering the excise tax (the “Excise Tax”) imposed by Section 4999 of the Code (the “Required Reduction”),
if such adjustment would result in the provision of a greater total benefit, on a net after-tax basis (after taking into account any applicable federal, state and local income and employment taxes and the
Excise Tax), to Executive. In the case of a reduction in the Total Payments, the Total Payments will be reduced in the following order: (i) by reducing any cash payments to be made to Executive (excluding any cash payment with respect to the
acceleration of equity-based compensation); (ii) by canceling the acceleration of vesting of any outstanding equity-based compensation awards; and (iii) by reducing any other non-cash benefits provided to
Executive. In the case of the reductions to be made pursuant to each of the above-mentioned clauses, the payment and/or benefit amounts to be reduced, and the acceleration of vesting to be cancelled, shall be reduced or cancelled in the inverse
order of their originally scheduled dates of payment or vesting, as applicable, and shall be so reduced: (x) only to the extent that the payment and/or benefit otherwise to be paid, or the vesting of the award that otherwise would be
accelerated, would be treated as a “parachute payment” within the meaning of Code Section 280G(b)(2)(A); and (y) only to the extent necessary to achieve the Required Reduction. All determinations made under this
Section 18(e) (as well as with respect to any payments provided to any other “disqualified individual” of the Company within the meaning of Section 280G(c) of the Code) shall be made by a nationally
recognized accounting or consulting firm as selected by the Company (the “Accounting Firm”) which shall provide detailed supporting calculations to Executive and the Company. All fees and expenses of the Accounting Firm shall be
borne by the Company. All determinations by the Accounting Firm shall be binding on Executive and the Company absent manifest error. 

  

	 	(f)	 Modification. No provision of this Agreement may be modified, waived, or discharged unless such waiver,
modification or discharge is agreed to in writing and signed by Executive and the Company. No waiver by either party hereto at any time of any breach by the other party hereto of, or compliance with, any condition or provision of this Agreement to
be performed by the other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. No agreement or representations, oral or otherwise, express or implied, with respect to the
subject matter hereof have been made by any party which are not expressly set forth in this Agreement. 

  

	 	(g)	 Anything herein to the contrary notwithstanding, the terms of this Agreement shall be modified to the extent
required to meet the provisions of any applicable law (whether Israeli or other) or other law applicable to the employment arrangements between Executive and the Company. Any delay in providing benefits or payments or any failure to provide a
benefit or payment shall not in and of itself constitute a breach of this Agreement 

  
 23 

	 	
as a result of applicable law; provided, however, that the Company shall provide economically equivalent payments or benefits to Executive to the extent permitted by law as soon as
practicable after such benefits or payments are due. Any request or requirement that Executive repay compensation that is required under the first sentence of this Section 18(g), or pursuant to a Company policy or policy of American Well
Corporation that is applicable to other executive officers of the Company or American Well Corporation and that is designed to advance the legitimate corporate governance objectives of the Company or American Well Corporation, shall not in and of
itself constitute a breach of this Agreement. 

  

	 	(h)	 Governing Law. This Agreement shall be governed by and construed and enforced in accordance with the
laws of Israel. 

  

	 	(i)	 No Conflicts. As a condition to the effectiveness of this Agreement, Executive represents and warrants
to the Company that Executive is not a party to or otherwise bound by any agreement or arrangement (including, without limitation, any license, covenant, or commitment of any nature), or subject to any judgment, decree, or order of any court or
administrative agency, that would conflict with or will be in conflict with or in any way preclude, limit or inhibit Executive’s ability to execute this Agreement or to carry out Executive’s duties and responsibilities hereunder. In the
event that the Company reasonably determines that Executive’s duties hereunder may conflict with an agreement or arrangement to which Executive is bound, Executive shall be required to cease engaging in any such activities, duties or
responsibilities (including providing supervisory services over certain subsets of the Company’s business operations) and the Company will take steps to restrict Executive’s access to, and participation in, any such activities, until the
Company determines that such conflict ceases to exist. Any actions taken by the Company under this Section 18(i) to restrict or limit Executive’s access to information or provision of services shall not
constitute Good Reason for purposes of Section 6(e) hereof. 

  

	 	(j)	 Severability. The provisions of this Agreement shall be deemed severable and the invalidity or
unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof. 

  

	 	(k)	 Effectiveness of Agreement. The effectiveness of this Agreement is contingent upon the occurrence of the
Commencement Date within the time provided in Section 1 hereof. 

  
 24 

 19.    Entire Agreement. This Agreement constitutes the entire
agreement between the parties hereto and supersedes all prior agreements, term sheets, understandings and arrangements, oral or written, between the parties hereto with respect to the subject matter hereof, including without limitation any term
sheets or other similar presentations, that certain Employment Agreement. Counterparts. This Agreement may be executed in separate counterparts, any one of which need not contain signatures of more than one party, but all of which taken together
will constitute one and the same Agreement. Signatures transmitted via facsimile or PDF will be deemed the equivalent of originals. IN WITNESS WHEREOF, the parties have executed this Employment Agreement as of the day and year first above written,
to be effective as of the Effective Date. 
 -Signature Page Follows - 

  
 25 

 
			
	AMERICAN WELL CORPORATION
		
	By:	 	 /s/ Brad Gay

	Name:	 	Brad Gay
	Title:	 	General Counsel
	
	EXECUTIVE
		
	By:	 	 /s/ Phyllis Gotlib

	Name:	 	Phyllis Gotlib

  
 26 

 EXHIBIT A 

DEFINITIONS 
 For purposes of
Section 6(c) of this Agreement, the following shall constitute “Cause”: (1) Executive’s indictment or conviction for either a felony offense or any other crime involving, or participation in, any
fraud, theft or embezzlement; (2) willful breach of Executive’s duties of good faith and fair dealing that are owed to the Company or any of its subsidiaries; (3) Executive’s material breach or violation of any material agreement
between Executive and the Company or any of its subsidiaries; (4) willful and material failure to comply with the code of conduct of the Company or any of its subsidiaries or any other material policies of the Company that have been approved by
the board of directors of the Company (the “Board”) or its authorized delegate and which is materially harmful to the Company and its subsidiaries taken as a whole; or (5) Executive’s willful failure or refusal to follow
the lawful directions of the Company’s Chief Executive Officer (or co-Chief Executive Officers, if applicable) or the Board; provided that Executive shall have thirty (30) days after written
notice from the Company to cure the deficiency leading to the Cause determination (except with respect to prong (1) above, for which no notice is required) if, in the sole and reasonable discretion of the Board, such deficiency is curable; and
(6) any reason under which an employer is legally entitled to terminate employee’s employment with revoking employee’s right to severance pay and/or advanced notice period.  

For purposes of Section 6(e) of this Agreement, “Good Reason” means, without Executive’s express written
consent: (1) the relocation of Executive’s employment location to any other place which constitute as a worsening of the employment terms per applicable law, provided that the Executive refused the relocation; (2) the failure
by the Company to provide Executive with Executive’s Annual Salary, compensation and benefits in accordance with the terms of this Agreement, except for a reduction in Executive’s Annual Salary that is consistent with Annual Salary
reductions for similarly situated executives of the Company; (3) a material diminution in Executive’s authorities, responsibilities, position, reporting or job title as of immediately prior to such diminution; or (4) a material breach
by the Company of the terms of this Agreement. For the avoidance of doubt, Executive shall not be considered to have terminated Executive’s employment for Good Reason unless Executive has (A) not expressly consented in writing to the
occurrence that Executive alleges constitutes Good Reason; (B) given the Company written Notice of Termination for Good Reason not more than sixty (60) days after Executive’s knowledge of the initial existence of the alleged condition
giving rise to Good Reason; (C) given the Company at least thirty (30) days after receipt of such notice to cure the alleged deficiency; and (D) terminated Executive’s employment within sixty (60) days following the
Company’s receipt of such notice. 

 EXHIBIT B 

PRIOR INVENTIONS 
  

	1.	 The following is a complete list of all Prior Inventions (as provided in
Section 15(d) of the attached Employment Agreement): 

  

	2.	 Due to a prior confidentiality agreement, Executive cannot complete the disclosure under Section 1 above
with respect to the Prior Inventions generally listed below, the duty of confidentiality with respect to which Executive owes to the following party(ies): 

  

					
	 Prior Invention
	  	 Party(ies)
	  	 RelationshipExhibit 4.5

 

DESCRIPTION OF THE REGISTRANT’S SECURITIES

REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES

EXCHANGE ACT OF 1934

 

Minority
Equality Opportunities Acquisition Inc. (“we,” “our,” “us” or the “company”) has the following
three classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”):
(i) its units, each consisting of one share of Class A common stock and one redeemable warrant; (ii) Class A common stock, par value $0.0001
per share (the “Class A common stock” or “public shares”); and (iii) redeemable warrants, each whole warrant exercisable
for one share of Class A common stock at an exercise price of $11.50 per share. In addition, this Description of Securities also references
the company’s Class B common shares, par value $0.0001 per share (the “Class B common stock” or “founder shares”),
which are not registered pursuant to Section 12 of the Exchange Act but are convertible into Class A common stock. The description of
the Class B common stock is included to assist in the description of the Class A common stock. Unless the context otherwise requires,
references to our “sponsor” are to Minority Equality Opportunities Acquisition Sponsor, LLC and references to our “initial
stockholders” are to our sponsor, as they held our founder shares prior to our initial public offering.

 

Description of Capital Stock

 

The following description of our capital stock
is a summary and does not purport to be complete. It is subject to, and qualified in its entirety by reference to, our Amended and Restated
Certificate of Incorporation (our “certificate of incorporation”), and our bylaws, each of which are incorporated by reference
as an exhibit to the Annual Report on Form 10-K of which this Exhibit is a part. We encourage you to read our Certificate of Incorporation,
our Bylaws and the applicable provisions of the Delaware General Corporation Law (“DGCL”) for additional information.

 

Authorized Shares of Capital Stock

 

Pursuant to our certificate of incorporation,
our authorized capital stock consists of 100,000,000 shares of Class A common stock, 20,000,000 shares of Class B common stock, and 1,000,000
shares of undesignated preferred stock, $0.0001 par value.

 

Units

 

Each unit has an offering price of $10.00 and
consists of one share of Class A common stock and one redeemable warrant, subject to adjustment as discussed below. The Class A common
stock and warrants comprising the units began separate trading on October 18, 2021. Following the commencement of separate trading, holders
now have the option to continue to hold units or separate their units into the component securities. Holders will need to have their brokers
contact our transfer agent in order to separate the units into shares of Class A common stock and warrants.

 

Common Stock

 

Common stockholders of record are entitled to
one vote for each share held on all matters to be voted on by stockholders. Holders of the Class A common stock and holders of the Class
B common stock will vote together as a single class on all matters submitted to a vote of our stockholders, except as required by law.
Unless specified in our certificate of incorporation or bylaws, or as required by applicable provisions of the DGCL or applicable stock
exchange rules, the affirmative vote of a majority of our shares of common stock that are voted is required to approve any such matter
voted on by our stockholders. Our board of directors will be divided into 2 classes, each of which will generally serve for a term of
2 years with only one class of directors being elected in each year. There is no cumulative voting with respect to the election of directors,
with the result that the holders of more than 50% of the shares voted for the election of directors can elect all of the directors. Our
stockholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available
therefor.

 

Because our certificate of incorporation authorizes
the issuance of up to 100,000,000 shares of Class A common stock, if we were to enter into an initial business combination, we may (depending
on the terms of such an initial business combination) be required to increase the number of shares of Class A common stock which we are
authorized to issue at the same time as our stockholders vote on the initial business combination, to the extent we seek stockholder approval
in connection with our initial business combination.

 

    

     

    

 

In accordance with Nasdaq corporate governance
requirements, we are not required to hold an annual meeting until no later than one year after our first fiscal year end following our
listing on Nasdaq. Under Section 211(b) of the DGCL, we are, however, required to hold an annual meeting of stockholders for the purposes
of electing directors in accordance with our bylaws, unless such election is made by written consent in lieu of such a meeting. We may
not hold an annual meeting of stockholders to elect new directors prior to the consummation of our initial business combination, and thus
we may not be in compliance with Section 211(b) of the DGCL, which requires an annual meeting. Therefore, if our stockholders want us
to hold an annual meeting prior to the consummation of our initial business combination, they may attempt to force us to hold one by submitting
an application to the Delaware Court of Chancery in accordance with Section 211(c) of the DGCL.

 

We will provide our stockholders with the opportunity
to redeem all or a portion of their public shares upon the completion of our initial business combination at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the trust account as of two business days prior to the consummation of our initial
business combination including interest earned on the funds held in the trust account and not previously released to us to pay our franchise
and income taxes, divided by the number of then outstanding public shares, subject to the limitations described herein. The amount in
the trust account is initially anticipated to be approximately $10.15 per public share. The per-share amount we will distribute to investors
who properly redeem their shares will not be reduced by the deferred underwriting commissions we will pay to the underwriters. Our sponsor,
officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights
with respect to any founder shares and any public shares held by them in connection with the completion of our initial business combination.
Unlike many blank check companies that hold stockholder votes and conduct proxy solicitations in conjunction with their initial business
combinations and provide for related redemptions of public shares for cash upon completion of such initial business combinations even
when a vote is not required by law, if a stockholder vote is not required by law and we do not decide to hold a stockholder vote for business
or other legal reasons, we will, pursuant to our certificate of incorporation, conduct the redemptions pursuant to the tender offer rules
of the SEC, and file tender offer documents with the Securities and Exchange Commission (“SEC”) prior to completing our initial
business combination. Our certificate of incorporation requires these tender offer documents to contain substantially the same financial
and other information about the initial business combination and the redemption rights as is required under the SEC’s proxy rules.
If, however, a stockholder approval of the transaction is required by law, or we decide to obtain stockholder approval for business or
other legal reasons, we will, like many blank check companies, offer to redeem shares in conjunction with a proxy solicitation pursuant
to the proxy rules and not pursuant to the tender offer rules. If we seek stockholder approval, we will complete our initial business
combination only if a majority of the outstanding shares of common stock voted are voted in favor of the initial business combination.
A quorum for such meeting will consist of the holders present in person or by proxy of shares of outstanding capital stock of the company
representing a majority of the voting power of all outstanding shares of capital stock of the company entitled to vote at such meeting.

 

However, the participation of our sponsor, officers,
directors, advisors or their affiliates in privately negotiated transactions, if any, could result in the approval of our initial business
combination even if a majority of our public stockholders vote, or indicate their intention to vote, against such business combination.
For purposes of seeking approval of the majority of our outstanding shares of common stock voted, non-votes will have no effect on the
approval of our initial business combination once a quorum is obtained. We intend to give approximately 30 days’ (but not less than
10 days’ nor more than 60 days’) prior written notice of any such meeting, if required, at which a vote shall be taken to
approve our initial business combination. These quorum and voting thresholds, and the voting agreements of our initial stockholders, may
make it more likely that we will consummate our initial business combination.

 

If we seek stockholder approval of our initial
business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer
rules, our certificate of incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other
person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act),
will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the shares of common stock sold in this
offering, which we refer to as the Excess Shares. However, we would not be restricting our stockholders’ ability to vote all of
their shares (including Excess Shares) for or against our initial business combination. Our stockholders’ inability to redeem the
Excess Shares will reduce their influence over our ability to complete our initial business combination, and such stockholders could suffer
a material loss in their investment if they sell such Excess Shares on the open market. Additionally, such stockholders will not receive
redemption distributions with respect to the Excess Shares if we complete the initial business combination. And, as a result, such stockholders
will continue to hold that number of shares exceeding 15% and, in order to dispose such shares would be required to sell their stock in
open market transactions, potentially at a loss.

 

    2

     

    

 

If we seek stockholder approval in connection
with our initial business combination, pursuant to the letter agreement our sponsor, officers and directors have agreed to vote their
founder shares and any public shares purchased during or after our initial public offering (including in open market and privately negotiated
transactions) in favor of our initial business combination. As a result, in addition to our initial stockholders’ founder shares,
we would need only 4,822,813, or approximately 38.13%, (assuming all outstanding shares are voted), or 830,157, or approximately 6.56%
(assuming only the minimum number of shares representing a quorum are voted), of the 12,650,000 public shares sold in this offering to
be voted in favor of an initial business combination. Additionally, each public stockholder may elect to redeem its public shares irrespective
of whether they vote for or against the proposed transaction (subject to the limitation described in the preceding paragraph).

 

Pursuant to our certificate of incorporation,
if we are unable to complete our initial business combination within 12 months from the closing of our initial public offering (or 21
months from the closing, if we extend the period of time to consummate a business combination,), we will: (i) cease all operations except
for the purpose of winding up; (ii) as promptly as reasonably possible but no more than 10 business days thereafter subject to lawfully
available funds therefor, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit
in the trust account including interest earned on the funds held in the trust account and not previously released to us to pay our franchise
and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares,
which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further
liquidating distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of our remaining stockholders and our board of directors, dissolve and liquidate, subject in each case to our
obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. Our sponsor, officers
and directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their rights to liquidating distributions
from the trust account with respect to any founder shares held by them if we fail to complete our initial business combination within
12 months from the closing of our initial public offering (or 21 months from the closing, if we extend the period of time to consummate
a business combination). However, if our initial stockholders acquire public shares, they will be entitled to liquidating distributions
from the trust account with respect to such public shares if we fail to complete our initial business combination within the prescribed
time period.

 

In the event of a liquidation, dissolution or
winding up of the company after an initial business combination, our stockholders are entitled to share ratably in all assets remaining
available for distribution to them after payment of liabilities and after provision is made for each class of stock, if any, having preference
over the common stock. Our stockholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable
to the common stock, except that we will provide our stockholders with the opportunity to redeem their public shares for cash equal to
their pro rata share of the aggregate amount then on deposit in the trust account, upon the completion of our initial business combination,
subject to the limitations described herein.

 

Founder Shares

 

The founder shares are identical to the shares
of Class A common stock, and holders of founder shares have the same stockholder rights as public stockholders, except that: (i) the founder
shares are subject to certain transfer restrictions, as described in more detail below; (ii) our sponsor, officers and directors have
entered into a letter agreement with us, pursuant to which they have agreed: (A) to waive their redemption rights with respect to any
founder shares and any public shares held by them in connection with the completion of our initial business combination; (B) to waive
their redemption rights with respect to their founder shares and public shares in connection with a stockholder vote to approve an amendment
to our certificate of incorporation: (x) to modify the substance or timing of our obligation to redeem 100% of our public shares if we
do not complete our initial business combination within 12 months from the closing of our initial public offering (or 21 months from the
closing, if we extend the period of time to consummate a business combination); or (y) with respect to any other provision relating to
stockholders’ rights or pre-initial business combination activity; and (C) to waive their rights to liquidating distributions from
the trust account with respect to any founder shares held by them if we fail to complete our initial business combination within 12 months
from the closing of our initial public offering (or 21 months from the closing, if we extend the period of time to consummate a business
combination), although they will be entitled to liquidating distributions from the trust account with respect to any public shares they
hold if we fail to complete our initial business combination within such time period; (iii) the founder shares are shares of our Class
B common stock that will automatically convert into shares of our Class A common stock at the time of our initial business combination,
or at any time prior thereto at the option of the holder, on a one-for-one basis, subject to adjustment as described herein; and (iv)
are entitled to registration rights. If we submit our initial business combination to our public stockholders for a vote, our sponsor,
officers and directors have agreed pursuant to the letter agreement to vote any founder shares and public shares held by them in favor
of our initial business combination.

 

    3

     

    

 

The shares of Class B common stock will automatically
convert into shares of Class A common stock at the time of our initial business combination on a one-for-one basis (subject to adjustment
for stock splits, stock dividends, reorganizations, recapitalizations, and the like), and subject to further adjustment as provided herein.
In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued and related to the
closing of the initial business combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common
stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment
with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of
all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares
of common stock outstanding upon completion of our initial public offering, plus all shares of Class A common stock and equity-linked
securities issued or deemed issued in connection with the initial business combination (excluding any shares or equity-linked securities
issued, or to be issued, to any seller in the initial business combination, any private placement-equivalent securities issued to our
sponsor or its affiliates upon conversion of loans made to us).

 

We cannot determine at this time whether a majority
of the holders of our Class B common stock at the time of any future issuance would agree to waive such adjustment to the conversion ratio.
They may waive such adjustment due to (but not limited to) the following: (i) closing conditions which are part of the agreement for our
initial business combination; (ii) negotiation with Class A stockholders on structuring an initial business combination; or (iii) negotiation
with parties providing financing which would trigger the anti-dilution provisions of the Class B common stock. If such adjustment is not
waived, the issuance would not reduce the percentage ownership of holders of our Class B common stock, but would reduce the percentage
ownership of holders of our Class A common stock. If such adjustment is waived, the issuance would reduce the percentage ownership of
holders of both classes of our common stock. Holders of founder shares may also elect to convert their shares of Class B common stock
into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time. The term “equity-linked
securities” refers to any debt or equity securities that are convertible, exercisable or exchangeable for shares of Class A common
stock issued in a financing transaction in connection with our initial business combination, including but not limited to a private placement
of equity or debt. Securities could be “deemed issued” for purposes of the conversion rate adjustment if such shares are issuable
upon the conversion or exercise of convertible securities, warrants or similar securities.

 

Our initial stockholders have agreed not to transfer,
assign or sell any of their founder shares until the earlier to occur of: (i) one year after the date of the consummation of our initial
business combination; or (ii) the date on which we consummate a liquidation, merger, stock exchange or other similar transaction which
results in all of our stockholders having the right to exchange their shares of Class A common stock for cash, securities or other property.
Any permitted transferees will be subject to the same restrictions and other agreements of our initial stockholders with respect to any
founder shares. Notwithstanding the foregoing, if the closing price of our shares of Class A common stock equals or exceeds $12.00 per
share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within
any 30-trading day period commencing 150 days after our initial business combination, the founder shares will no longer be subject to
such transfer restrictions.

 

    4

     

    

 

Preferred Stock

 

Our certificate of incorporation provides that
shares of preferred stock may be issued from time to time in one or more series. Our board of directors is authorized to fix the voting
rights, if any, designations, powers, preferences, the relative, participating, optional, or other special rights and any qualifications,
limitations, and restrictions thereof, applicable to the shares of each series. Our board of directors will be able to, without stockholder
approval, issue preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders
of the common stock and could have anti-takeover effects. The ability of our board of directors to issue preferred stock without stockholder
approval could have the effect of delaying, deferring, or preventing a change of control of us or the removal of existing management.
We have no preferred stock outstanding at the date hereof. Although we do not currently intend to issue any shares of preferred stock,
we cannot assure you that we will not do so in the future.

 

While we have no current plans to issue preferred
stock, circumstances in which we might issue preferred stock in the future could include, among others, offerings of preferred stock undertaken
for capital raising purposes (whether before or in connection with our initial business combination or thereafter), issuances in connection
with acquisitions we might make in the future, or issuances in connection with potential change of control or strategic transactions involving
us. Any determination by us to issue shares of preferred stock in the future will be dependent on the facts and circumstances at the time.

 

Warrants

 

Public Stockholders’ Warrants

 

Each warrant entitles the holder thereof to purchase
one share of Class A common stock at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing on
the later of 12 months from the closing of our initial public offering or 30 days after the completion of our initial business combination.
The warrants will expire five years after the completion of our initial business combination, at 5:00 pm., New York City time, or earlier
upon redemption or liquidation.

 

We will not be obligated to deliver any shares
of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration
statement under the Securities Act of 1933, as amended (the “Securities Act”), with respect to the shares of Class A common
stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to our satisfying our obligations
described below with respect to registration. No warrant will be exercisable and we will not be obligated to issue shares of Class A common
stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed
to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions
in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled
to exercise such warrant and such warrant may have no value and expire worthless. In no event will we be required to net cash settle any
warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such
warrant will have paid the full purchase price for the unit solely for the share of Class A common stock underlying such unit.

 

We are not registering the shares of Class A common
stock issuable upon exercise of the warrants at this time. However, we have agreed that as soon as practicable, but in no event later
than 15 business days after the closing of our initial business combination, we will use our reasonable best efforts: to file with the
SEC a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants, to cause such registration
statement to become effective, and to maintain a current prospectus relating to those shares of Class A common stock until the warrants
expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class A common stock
issuable upon exercise of the warrants is not effective by the 60th business day after the closing of our initial business
combination, warrant holders may, until such time as there is an effective registration statement and during any period when we will have
failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section
3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if our Class A common stock is at the time of any exercise
of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under
Section 18(b)(1) of the Securities Act, we may, at our option, require holders of public warrants who exercise their warrants to do so
on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event we so elect, we will not
be required to file or maintain in effect a registration statement, but we will be required to use our reasonable best efforts to register
or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

 

    5

     

    

 

Once the warrants become exercisable, we may call
the warrants for redemption (other than the private placement warrants):

 

	 	●	in whole and not in part;
	 	 	 
	 	●	at a price of $0.01 per warrant;
	 	 	 
	 	●	upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and
	 	 	 
	 	●	if, and only if, the reported last sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending 3 business days before we send the notice of redemption to the warrant holders.
	 	 	 

If and when the warrants become redeemable by
us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable
state securities laws.

 

We have established the last of the redemption
criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise
price. If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled
to exercise its warrant prior to the scheduled redemption date. However, the price of the Class A common stock may fall below the $18.00
redemption trigger price (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations, and the like) as well as
the $11.50 warrant exercise price after the redemption notice is issued.

 

If we call the warrants for redemption as described
above, our management will have the option to require any holder that wishes to exercise its warrant to do so on a “cashless basis.”
In determining whether to require all holders to exercise their warrants on a “cashless basis,” our management will consider,
among other factors, our cash position, the number of warrants that are outstanding and the dilutive effect on our stockholders of issuing
the maximum number of shares of Class A common stock issuable upon the exercise of our warrants. If our management takes advantage of
this option, all holders of warrants would pay the exercise price by surrendering their warrants for that number of shares of Class A
common stock equal to the quotient obtained by dividing: (x) the product of the number of shares of Class A common stock underlying the
warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below);
by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the Class A common
stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders
of warrants. If our management takes advantage of this option, the notice of redemption will contain the information necessary to calculate
the number of shares of Class A common stock to be received upon exercise of the warrants, including the “fair market value”
in such case. Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive
effect of a warrant redemption. We believe this feature is an attractive option to us if we do not need the cash from the exercise of
the warrants after our initial business combination. If we call our warrants for redemption and our management does not take advantage
of this option, our sponsor and its permitted transferees would still be entitled to exercise their private placement warrants for cash
or on a cashless basis using the same formula described above that other warrant holders would have been required to use had all warrant
holders been required to exercise their warrants on a cashless basis, as described in more detail below.

 

A holder of a warrant may notify us in writing
in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent
that after giving effect to such exercise, such person (together with such person’s affiliates), to the warrant agent’s actual
knowledge, would beneficially own in excess of 4.9% or 9.8% (or such other amount as a holder may specify) of the shares of Class A common
stock outstanding immediately after giving effect to such exercise.

 

    6

     

    

 

If the number of outstanding shares of Class A
common stock is increased by a stock dividend payable in shares of Class A common stock, or by a split-up of shares of Class A common
stock or other similar event, then, on the effective date of such stock dividend, split-up or similar event, the number of shares of Class
A common stock issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding shares of Class
A common stock. A rights offering to holders of Class A common stock entitling holders to purchase shares of Class A common stock at a
price less than the fair market value will be deemed a stock dividend of a number of shares of Class A common stock equal to the product
of: (i) the number of shares of Class A common stock actually sold in such rights offering (or issuable under any other equity securities
sold in such rights offering that are convertible into or exercisable for Class A common stock); and (ii) one (1) minus the quotient of:
(x) the price per share of Class A common stock paid in such rights offering, divided by (y) the fair market value. For these purposes:
(i) if the rights offering is for securities convertible into or exercisable for Class A common stock, in determining the price payable
for Class A common stock, there will be taken into account any consideration received for such rights, as well as any additional amount
payable upon exercise or conversion; and (ii) fair market value means the volume weighted average price of Class A common stock as reported
during the ten (10) trading day period ending on the trading day prior to the first date on which the shares of Class A common stock trade
on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

 

In addition, if we, at any time while the warrants
are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to the holders of Class A common
stock on account of such shares of Class A common stock (or other shares of our capital stock into which the warrants are convertible),
other than: (a) as described above; (b) certain ordinary cash dividends; (c) to satisfy the redemption rights of the holders of Class
A common stock in connection with a proposed initial business combination; (d) to satisfy the redemption rights of the holders of Class
A common stock in connection with a stockholder vote to amend our certificate of incorporation: (1) to modify the substance or timing
of our obligation to redeem 100% of our Class A common stock if we do not complete our initial business combination within 12 months from
the closing of our initial public offering (or 21 months from the closing, if we extend the period of time to consummate a business combination);
or (2) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity; or (e)
in connection with the redemption of our public shares upon our failure to complete our initial business combination, then the warrant
exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair
market value of any securities or other assets paid on each share of Class A common stock in respect of such event.

 

If the number of outstanding shares of our Class
A common stock is decreased by a consolidation, combination, reverse stock split or reclassification of shares of Class A common stock
or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar
event, the number of shares of Class A common stock issuable on exercise of each warrant will be decreased in proportion to such decrease
in outstanding shares of Class A common stock.

 

Whenever the number of shares of Class A common
stock purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying
the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of shares
of Class A common stock purchasable upon the exercise of the warrants immediately prior to such adjustment, and (y) the denominator of
which will be the number of shares of Class A common stock so purchasable immediately thereafter.

 

In case of any reclassification or reorganization
of the outstanding shares of Class A common stock (other than those described above or that solely affects the par value of such shares
of Class A common stock), or in the case of any merger or consolidation of us with or into another corporation (other than a consolidation
or merger in which we are the continuing corporation and that does not result in any reclassification or reorganization of our outstanding
shares of Class A common stock), or in the case of any sale or conveyance to another corporation or entity of the assets or other property
of us as an entirety or substantially as an entirety in connection with which we are dissolved, the holders of the warrants will thereafter
have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in lieu of the
shares of our Class A common stock immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby,
the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization,
merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received
if such holder had exercised their warrants immediately prior to such event. If less than 70% of the consideration receivable by the holders
of Class A common stock in such a transaction is payable in the form of Class A common stock in the successor entity that is listed for
trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or
quoted immediately following such event, and if the registered holder of the warrant properly exercises the warrant within thirty days
following public disclosure of such transaction, the warrant exercise price will be reduced as specified in the warrant agreement based
on the Black-Scholes value (as defined in the warrant agreement) of the warrant. The purpose of such exercise price reduction is to provide
additional value to holders of the warrants when an extraordinary transaction occurs during the exercise period of the warrants pursuant
to which the holders of the warrants otherwise do not receive the full potential value of the warrants.

 

    7

     

    

 

The warrants were issued in registered form under
a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The description of the warrants
set forth herein is a summary and does not purport to be complete. It is subject to, and qualified in its entirety by reference to, the
warrant agreement, which is incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this Exhibit is a part.
The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or
correct any defective provision, but requires the approval by the holders of at least 65% of the then outstanding public warrants to make
any change that adversely affects the interests of the registered holders of public warrants.

 

The warrants may be exercised upon surrender of
the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse
side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless
basis, if applicable), by certified or official bank check payable to us, for the number of warrants being exercised. The warrant holders
do not have the rights or privileges of holders of Class A common stock and any voting rights until they exercise their warrants and receive
shares of Class A common stock. After the issuance of shares of Class A common stock upon exercise of the warrants, each holder will be
entitled to one (1) vote for each share held of record on all matters to be voted on by stockholders.

 

In addition, if: (x) we issue additional shares
of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of our initial business
combination at a Newly Issued Price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price
to be determined in good faith by our board of directors and, in the case of any such issuance to our sponsor or its affiliates, without
taking into account any founder shares held by our sponsor or its affiliates, prior to such issuance); (y) the aggregate gross proceeds
from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial
business combination on the date of the consummation of our initial business combination (net of redemptions); and (z) the Market Value
is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher
of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price (as adjusted for stock splits, stock
dividends, reorganizations, recapitalizations, and the like) will be adjusted (to the nearest cent) to be equal to 180% of the higher
of the Market Value and the Newly Issued Price.

 

We have agreed that, subject to applicable law,
any action, proceeding or claim against us arising out of or relating in any way to the warrant agreement will be brought and enforced
in the courts of the State of New York or the United States District Court for the Southern District of New York, and we irrevocably submit
to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding or claim. This provision applies
to claims under the Securities Act but does not apply to claims under the Exchange Act or any claim for which the federal district courts
of the United States of America are the sole and exclusive forum.

 

Private Placement Warrants

 

The private placement warrants (including
the Class A common stock issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable
until 30 days after the completion of our initial business combination (except, among other limited exceptions, to our officers and
directors and other persons or entities affiliated with our sponsor and the underwriter of our initial public offering) and they
will not be redeemable by us so long as they are held by our sponsor, the underwriter of our initial public offering or their
permitted transferees. Our sponsor, the underwriter of our initial public offering or their permitted transferees, has the option to
exercise the private placement warrants on a cashless basis. Except as described below, the private placement warrants have terms
and provisions that are identical to those of the warrants sold as part of the units in our initial public offering, including as to
exercise price, exercisability and exercise period. If the private placement warrants are held by holders other than the sponsor,
the underwriter of our initial public offering or their permitted transferees, the private placement warrants will be redeemable by
us and exercisable by the holders on the same basis as the warrants included in the units sold in our initial public offering.

 

    8

     

    

 

If holders of the private placement warrants elect
to exercise them on a cashless basis, they would pay the exercise price by surrendering their warrants for that number of shares of Class
A common stock equal to the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying the
warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below)
by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the Class A common
stock for the 10 trading days ending on the third trading day prior to the date on which the notice of warrant exercise is sent to the
warrant agent. The reason that we have agreed that these warrants will be exercisable on a cashless basis so long as they are held by
the sponsor, the underwriter of our initial public offering or their permitted transferees is because it is not known at this time whether
they will be affiliated with us following an initial business combination. If they remain affiliated with us, their ability to sell our
securities in the open market will be significantly limited. We expect to have policies in place that prohibit insiders from selling our
securities except during specific periods of time. Even during such periods of time when insiders will be permitted to sell our securities,
an insider cannot trade in our securities if he or she is in possession of material non-public information. Accordingly, unlike public
stockholders who could sell the shares of Class A common stock issuable upon exercise of the warrants freely in the open market, the insiders
could be significantly restricted from doing so. As a result, we believe that allowing the holders to exercise such warrants on a cashless
basis is appropriate.

 

In order to finance transaction costs in connection
with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may,
but are not obligated to, loan us funds as may be required. Up to $1,500,000 of such working capital loans may be convertible into private
placement-equivalent warrants at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the private
placement warrants, including as to exercise price, exercisability and exercise period. The terms of such working capital loans by our
sponsor or its affiliates, or our officers and directors, if any, have not been determined and no written agreements exist with respect
to such loans.

 

In addition, holders of our private placement warrants are entitled
to certain registration rights.

 

The holders of the private placement warrants
have agreed not to transfer, assign or sell any of the private placement warrants (including the Class A common stock issuable upon exercise
of any of these warrants) until the date that is 30 days after the date we complete our initial business combination (except, among other
limited exceptions, to our officers and directors and other persons or entities affiliated with our sponsor).

 

Dividends

 

We have not paid any cash dividends on our common
stock to date and do not intend to pay cash dividends prior to the completion of an initial business combination. The payment of cash
dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial conditions
subsequent to completion of an initial business combination. The payment of any cash dividends subsequent to an initial business combination
will be within the discretion of our board of directors at such time. Further, if we incur any indebtedness, our ability to declare dividends
may be limited by restrictive covenants we may agree to in connection therewith.

 

Our Transfer Agent and Warrant Agent

 

The transfer agent for our common stock and the
warrant agent for our warrants is Continental Stock Transfer & Trust Company. We have agreed to indemnify Continental Stock Transfer
& Trust Company in its roles as transfer agent and warrant agent, its agents and each of its stockholders, directors, officers and
employees against all claims and losses that may arise out of acts performed or omitted for its activities in that capacity, except for
any liability due to any gross negligence, willful misconduct or bad faith of the indemnified person or entity.

 

    9

     

    

 

Our Certificate of Incorporation

 

Our certificate of incorporation contains certain
requirements and restrictions that apply to us until the completion of our initial business combination. These provisions cannot be amended
without the approval of the holders of 65% of our common stock. Our initial stockholders, who will collectively beneficially own approximately
20% of our common stock (not including the shares of Class A common stock issuable to the underwriters upon completion of our initial
public offering), will participate in any vote to amend our certificate of incorporation and will have the discretion to vote in any manner
they choose. Specifically, our certificate of incorporation provides, among other things, that:

 

	 	●	If we are unable to complete our initial business combination within 12 months from the closing of our initial public offering (or 21 months from the closing, if we extend the period of time to consummate a business combination), we will: (i) cease all operations, except for the purpose of winding up; (ii) as promptly as reasonably possible, but not more than 10 business days thereafter subject to lawfully available funds therefor, redeem 100% of the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law;
	 	 	 
	 	●	Prior to our initial business combination, we may not issue additional shares of capital stock that would entitle the holders thereof to: (i) receive funds from the trust account; or (ii) vote on any initial business combination;
	 	 	 
	 	●	Although we do not intend to enter into an initial business combination with a target business that is affiliated with our sponsor, our directors or our officers, we are not prohibited from doing so. In the event we enter into such a transaction, we, or a committee of independent directors, will obtain an opinion from an independent investment banking firm that is a member of FINRA or an independent accounting firm that such an initial business combination is fair to our company from a financial point of view;
	 	 	 
	 	●	If a stockholder vote on our initial business combination is not required by law and we do not decide to hold a stockholder vote for business or other legal reasons, we will offer to redeem our public shares pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, and will file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about our initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act; whether or not we maintain our registration under the our Exchange Act or our listing on Nasdaq, we will provide our public stockholders with the opportunity to redeem their public shares by one of the two methods listed above;
	 	 	 
	 	●	So long as we obtain and maintain a listing for our securities on Nasdaq, Nasdaq rules require that we must complete one or more business combinations having an aggregate fair market value of at least 80% of the value of the assets held in the trust account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the trust account) at the time of our signing a definitive agreement in connection with our initial business combination;
	 	 	 
	 	●	If our stockholders
    approve an amendment to our certificate of incorporation: (i) to modify the substance or timing of our obligation to redeem 100% of
    our public shares if we do not complete our initial business combination within 12 months from the closing of our initial public
    offering (or 21 months from the closing, if we extend the period of time to consummate a business combination); or (ii) with respect
    to any other provision relating to stockholders’ rights or pre- business combination activity, we will provide our public stockholders with the opportunity to redeem all or a portion of their shares of Class A common stock upon such approval at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our franchise and income taxes, divided by the number of then outstanding public shares; and

 

    10

     

    

 

	 	●	We will not effectuate our initial business combination with another blank check company or a similar company with nominal operations.
	 	 	 

In addition, our certificate of incorporation
provides that under no circumstances will we redeem our public shares in an amount that would cause our net tangible assets to be less
than $5,000,001 either immediately prior to or upon consummation of our initial business combination and after payment of the underwriters’
fees and commissions.

 

Certain Anti-Takeover Provisions of Delaware Law and our Certificate
of incorporation and Bylaws

 

We are subject to the provisions of Section 203
of the DGCL regulating corporate takeovers. This statute prevents certain Delaware corporations, under certain circumstances, from engaging
in a “business combination” with:

 

	 	●	a stockholder who owns 15% or more of our outstanding voting stock (otherwise known as an “interested stockholder”);
	 	 	 
	 	●	an affiliate of an interested stockholder; or
	 	 	 
	 	●	an associate of an interested stockholder, for three years following the date that the stockholder became an interested stockholder.

 

A “business combination” includes
a merger or sale of more than 10% of our assets. However, the above provisions of Section 203 do not apply if:

 

	 	●	our board of directors approves the transaction that made the stockholder an “interested stockholder,” prior to the date of the transaction;
	 	 	 
	 	●	after the completion of the transaction that resulted in the stockholder becoming an interested stockholder, that stockholder owned at least 85% of our voting stock outstanding at the time the transaction commenced, other than statutorily excluded shares of common stock; or
	 	 	 
	 	●	on or subsequent to the date of the transaction, the initial business combination is approved by our board of directors and authorized at a meeting of our stockholders, and not by written consent, by an affirmative vote of at least two-thirds of the outstanding voting stock not owned by the interested stockholder.

 

Our certificate of incorporation provides that
our board of directors is classified into 2 classes of directors. As a result, in most circumstances, a person can gain control of our
board only by successfully engaging in a proxy contest at two or more annual meetings.

 

Our authorized but unissued common stock and preferred
stock are available for future issuances without stockholder approval and could be utilized for a variety of corporate purposes, including
future offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved
common stock and preferred stock could render more difficult or discourage an attempt to obtain control of us by means of a proxy contest,
tender offer, merger or otherwise.

 

    11

     

    

 

Exclusive forum for certain lawsuits

 

Our certificate of incorporation requires, to
the fullest extent permitted by law, that derivative actions brought in our name, actions against directors, officers and employees for
breach of fiduciary duty and certain other actions may be brought only in the Court of Chancery in the State of Delaware, except any action:
(A) as to which the Court of Chancery in the State of Delaware determines that there is an indispensable party not subject to the jurisdiction
of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within 10
days following such determination); (B) which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery;
or (C) for which the Court of Chancery does not have subject matter jurisdiction. If an action is brought outside of Delaware, the stockholder
bringing the suit will be deemed to have consented to service of process on such stockholder’s counsel. Although we believe this
provision benefits us by providing increased consistency in the application of law in the types of lawsuits to which it applies, a court
may determine that this provision is unenforceable, and to the extent it is enforceable, the provision may have the effect of discouraging
lawsuits against our directors and officers.

 

Our certificate of incorporation provides that
the exclusive forum provision will be applicable to the fullest extent permitted by applicable law, subject to certain exceptions. Section
27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange
Act or the rules and regulations thereunder. As a result, the exclusive forum provision will not apply to suits brought to enforce any
duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. In addition,
our certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, the federal district
courts of the United States of America shall, to the fullest extent permitted by law, be the exclusive forum for the resolution of any
complaint asserting a cause of action arising under the Securities Act of 1933, as amended, or the rules and regulations promulgated thereunder.
We note, however, that there is uncertainty as to whether a court would enforce this provision and that investors cannot waive compliance
with the federal securities laws and the rules and regulations thereunder. Section 22 of the Securities Act creates concurrent jurisdiction
for state and federal courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations
thereunder.

 

Special meeting of stockholders

 

Our bylaws provide that special meetings of our
stockholders may be called only by a majority vote of our board of directors, by our Chief Executive Officer or by our Chairman.

 

Advance notice requirements for stockholder proposals and director
nominations

 

Our bylaws provide that stockholders seeking to
bring business before our annual meeting of stockholders, or to nominate candidates for election as directors at our annual meeting of
stockholders, must provide timely notice of their intent in writing. To be timely, a stockholder’s notice will need to be received
by the company secretary at our principal executive offices not later than the close of business on the 90th day nor earlier
than the opening of business on the 120th day prior to the anniversary date of the immediately preceding annual meeting of
stockholders. Pursuant to Rule 14a-8 of the Exchange Act, proposals seeking inclusion in our annual proxy statement must comply with the
notice periods contained therein. Our bylaws also specify certain requirements as to the form and content of a stockholders’ meeting.
These provisions may preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations
for directors at our annual meeting of stockholders.

 

Action by written consent

 

Subsequent to the consummation of the offering,
any action required or permitted to be taken by our common stockholders must be effected by a duly called annual or special meeting of
such stockholders and may not be effected by written consent of the stockholders other than with respect to our Class B common stock.

 

Classified Board of Directors

 

Our board of directors is divided into 2 classes,
Class I and Class II, with members of each class serving staggered 2-year terms. Our certificate of incorporation provides that the authorized
number of directors may be changed only by resolution of the board of directors. Subject to the terms of any preferred stock, any or all
of the directors may be removed from office at any time, but only for cause and only by the affirmative vote of holders of a majority
of the voting power of all then outstanding shares of our capital stock entitled to vote generally in the election of directors, voting
together as a single class. Any vacancy on our board of directors, including a vacancy resulting from an enlargement of our board of directors,
may be filled only by vote of a majority of our directors then in office.

 

    12

     

    

 

Class B Common Stock Consent Right

 

For so long as any shares of Class B common stock
remain outstanding, we may not, without the prior vote or written consent of the holders of a majority of the shares of Class B common
stock then outstanding, voting separately as a single class, amend, alter or repeal any provision our certificate of incorporation, whether
by merger, consolidation or otherwise, if such amendment, alteration or repeal would alter or change the powers, preferences or relative,
participating, optional or other or special rights of the Class B common stock. Any action required or permitted to be taken at any meeting
of the holders of Class B common stock may be taken without a meeting, without prior notice and without a vote, if a consent or consents
in writing, setting forth the action so taken, shall be signed by the holders of the outstanding Class B common stock having not less
than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares of Class B
common stock were present and voted.

 

Registration Rights

 

The holders of the founder shares (and any shares
of Class A common stock issuable upon conversion of the founder shares), private placement warrants (and any shares of Class A common
stock issuable upon conversion of the private placement warrants), the shares that were issued to the underwriter of our initial public
offering as compensation for services rendered in connection with such offering, and securities that may be issued upon conversion of
working capital loans (and any securities that may be issued upon conversion of working capital loans) will be entitled to registration
rights pursuant to a registration rights agreement, requiring us to register such securities for resale (in the case of the founder shares,
only after conversion to our Class A common stock). The holders of the majority of these securities are entitled to make up to three demands,
excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration
rights with respect to registration statements filed subsequent to our completion of our initial business combination and rights to require
us to register for resale such securities pursuant to Rule 415 under the Securities Act. Notwithstanding the foregoing, these holders
may not exercise their demand and “piggyback” registration rights after five and seven years after the effective date of the
registration statement for our initial public offering and may not exercise their demand rights on more than one occasion. We will bear
the expenses incurred in connection with the filing of any such registration statements.

 

Listing of Securities

 

Our units, Class A common stock and warrants are listed on Nasdaq under
the symbols “MEOAU,” “MEOA” and “MEOAW,” respectively.

 

    13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]